Skip to content

Author

D. Dubchev

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

TARGETED THERAPY AND IMMUNOTHERAPY IN COMBINED ANAPLASTIC AND PAPILLARY THYROID CARCINOMA WITH BRAF V600E MUTATION AND PD-L1 EXPRESSION: A CLINICAL CASE

Targeted therapy demonstrates temporary efficacy in anaplastic thyroid carcinoma; however, the development of resistance and the aggressive nature of the disease significantly limit long-term treatment outcomes.

N. Sloneva, I. Turkpenova, D. Dubchev · 0 citations